arrow
R

Ranran Wu

ut md anderson cancer center
H指数:21
被引数:1,170

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer

囊泡介导的线粒体清除在 triple-negative breast cancer 中呈现出可操作性的代谢脆弱性

2025-12-160
OAAI
Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion

可燃卷烟与电子烟暴露对KRAS突变型肺癌促进作用的比较效应

2025-06-130
PRE
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
2024-11-090
OAAI
Disruption of sulfatide metabolism by targeting UGT8 is an actionable metabolic vulnerability for pancreatic cancer early interception
2024-09-150
PRE
Integrated spatial transcriptomics and lipidomics analyses of intraductal papillary mucinous neoplasm identifies enrichment of long chain sulfatide as an early metabolic alteration
2024-03-220
PRE
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

调节益生元食物来源影响炎症和免疫调节肠道微生物和代谢物: 来自BE GONE试验的见解

2023-12-0110
OAAI
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
2023-09-272
OAAI
A blood-based metabolomic signature predictive of risk for pancreatic cancer
2023-09-0116
OAAI
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression
2023-06-123
OA
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in B cell lymphoma
2022-11-016
OAAI
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

应用人工智能预测三阴性乳腺癌新辅助化疗疗效的血浆代谢组学研究

2022-08-1111
OAAI
Targeting acetyl-CoA metabolism attenuates the formation of fear memories through reduced activity-dependent histone acetylation

靶向乙酰辅酶a代谢通过降低活性依赖性组蛋白乙酰化减弱恐惧记忆的形成

2022-08-0315
OAAI
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression
2021-07-2813
OA